The online home for the primary care professionals managing patients with cardiovascular disease, diabetes and related diseases.

Editorial

Sunday, 17 March 2013
We describe a patient with heart failure, diagnosed from clinical history and examination, and with a raised BNP. Despite treatment, her symptoms progressed. Echocardiography, performed after a six-month delay, showed a large mass. After excision of the mass, an atrial myxoma, the patient recovered rapidly and well.
Category: Editorial
Sunday, 17 March 2013
The ECG is the most commonly performed cardiac investigation but incorrectly recorded ECGs may lead to misdiagnosis. In this study, questionnaires were used to assess the pre-training perceived and actual knowledge of correct ECG recording technique among 54 primary care staff. Training was then performed and, after training, many staff admitted that their previous practice had been incorrect some or all of the time and said that they would change their practice.
Category: Editorial
Sunday, 17 March 2013
Although primary care consultations appear to represent an excellent opportunity to discuss a patient's weight status, GPs may be reluctant to do so. Excess weight can be an extremely sensitive issue and some terms (such as obese and fat) may provoke highly negative emotions. People who are overweight or obese say they would find unsolicited advice off-putting, but would also be more likely to try to lose weight if advised by a health professional than by family or friends.
Category: Editorial
Sunday, 17 March 2013
A variety of cardiovascular disease (CVD) statin prescribing strategies are advocated for use in primary care. We defined four strategies: assorted drugs and doses (current practice); fixed doses targeting all men or women aged >55 years; targeting those at high Framingham CVD risk; and tailoring dose according to risk stratification. By combining price and potency data with our CVD patient risks database, we modelled potential benefit (myocardial infarctions [MIs] prevented), cost and numbers expected to be treated for each strategy.
Category: Editorial
Sunday, 17 March 2013
Important modifications to the NICE clinical guideline on management of hypertension include changes in definitions of the stages of hypertension, greater use of ambulatory and home blood pressure monitoring, changes in treatment recommendations for those aged over 80 and changes in antihypertensive drug treatment recommendations.
Category: Editorial
Wednesday, 19 December 2012
Issues and challenges in hypertension management today Dr Chris Arden GP, Chandlers Ford; GPSI Cardiology, Southampton Most hypertensive patients fail to achieve their target blood pressure despite treatment. As a result, they have a significantly increased risk of stroke and heart attack. Primary care professionals can correct this situation, reducing morbidity and mortality through accurate blood pressure measurement and effective treatment, often with more than one drug. The availability of a new angiotensin receptor blocker, Azilsartan medoxomil, provides an important addition to the choice of available treatment. This video offers primary care professionals a focussed review of high blood pressure, its measurement and modern treatment. This sponsored video has been organised and funded by Takeda UK  Prescribing Information for Edarbi®-(azilsartan medoxomil) can be seen hereCode: AZL121001d. Date of prep: December 2012
Category: Editorial
Monday, 17 December 2012
There were plenty of examples of both intellectual and communication skills at the Primary Care Cardiovascular Journal (PCCJ) and British Journal of Primary Care Nursing (BJPCN) conference, held at Scarman House, University of Warwick on the 16th-17th November 2012. The theme was 'Issues and answers in cardiovascular disease: applying the evidence in primary care today'.
Category: Editorial
Monday, 17 December 2012
Cardiovascular disease (CVD) risk assessment is a central part of the strategy for identification and treatment of high-risk cases, as was recognised in the National Institute for Health and Clinical Excellence (NICE) guidelines on lipid modification. A national strategy devised by the Department of Health for screening all individuals aged between 40 and 75 years exists in the UK though implementation and uptake have been variable. Unfortunately, in screening programmes the greatest uptake tends to be among the white population, wealthier people and women rather than among those groups in which CVD is over-represented: men, poor individuals and those from ethnic minorities. This has posed a great challenge to risk screening but non-traditional approaches including those in places of worship, pharmacies and communally-led initiatives seem to lead to greater success.
Category: Editorial

Article search and filter